Fereshteh Ameli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fereshteh Ameli has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A. Lossing
From the Division of Vascular Surgery, The Wellesley Hospital, University of Toronto
1 shared publicationAg Lossing
St. Michael’s Hospital, University of Toronto, Ontario, Canada
1 shared publicationD. Piazza
From the Division of Vascular Surgery, The Wellesley Hospital, University of Toronto
1 shared publicationGj Hicken
St. Michael's Hospital, University of Toronto, Ontario, Canada
1 shared publicationH.P. von Schroeder
From the Division of Vascular Surgery, The Wellesley Hospital, University of Toronto
1 shared publication- Iman Salahshourifar
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 15 March 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (2) , 105-114
Association study of TYMS gene expression with TYMS and ENOSF1 genetic variants in neoadjuvant chemotherapy response of gastric cancer
Background: The present research was designed to study the associations between genetic variants of TYMS and ENOSF1 genes with TYMS and ENOSF1 gene expression in neoadjuvant chemotherapy response among patients with gastric cancer. Methods: Formalin-embedded and paraffin-fixed matched tumor and normal gastric cancer tissue samples from patients who received neoadjuvant 5-fluorouracil (5-FU) treatment were obtained. DNA and RNA were extracted for all samples. A 28-bp variable number tandem repeat (VNTR) at the 5' untranslated region of TYMS gene and rs2612091 and rs2741171 variants in the ENOSF1 gene were genotyped for normal tissue samples. The real-time polymerase chain reaction method was used to study the expression of ENOSF1 and TYMS genes in both normal and tumor tissues. Data were analyzed using REST 2000 and SPSS ver. 26.0 software programs. Results: A significant association between TYMS 2R3R VNTR genotypes and 5-FU therapy was found (p = .032). The 3R3R and 2R2R genotypes were significantly associated with increased and decreased survival time, respectively (p = .003). The 3R3R genotype was significantly associated with TYMS overexpression (p < .001). Moreover, a significant association was found between the rs2612091 genotype and treatment outcome (p = .017). Conclusions: This study highlights the impact of TYMS and ENOSF1 genes as predictive indicators for survival and response to 5-FU–based neoadjuvant chemotherapy in gastric cancer patients.
- 15 March 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (2) , 105-114
Open AccessAssociation study of TYMS gene expression with TYMS and ENOSF1 genetic variants in neoadjuvant chemotherapy response of gastric cancer
Background: The present research was designed to study the associations between genetic variants of TYMS and ENOSF1 genes with TYMS and ENOSF1 gene expression in neoadjuvant chemotherapy response among patients with gastric cancer. Methods: Formalin-embedded and paraffin-fixed matched tumor and normal gastric cancer tissue samples from patients who received neoadjuvant 5-fluorouracil (5-FU) treatment were obtained. DNA and RNA were extracted for all samples. A 28-bp variable number tandem repeat (VNTR) at the 5' untranslated region of TYMS gene and rs2612091 and rs2741171 variants in the ENOSF1 gene were genotyped for normal tissue samples. The real-time polymerase chain reaction method was used to study the expression of ENOSF1 and TYMS genes in both normal and tumor tissues. Data were analyzed using REST 2000 and SPSS ver. 26.0 software programs. Results: A significant association between TYMS 2R3R VNTR genotypes and 5-FU therapy was found (p = .032). The 3R3R and 2R2R genotypes were significantly associated with increased and decreased survival time, respectively (p = .003). The 3R3R genotype was significantly associated with TYMS overexpression (p < .001). Moreover, a significant association was found between the rs2612091 genotype and treatment outcome (p = .017). Conclusions: This study highlights the impact of TYMS and ENOSF1 genes as predictive indicators for survival and response to 5-FU–based neoadjuvant chemotherapy in gastric cancer patients.
- 1 October 2000
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 20 (4) , 336-341
Assessment of Generic Health-related Quality of Life in Patients with Intermittent Claudication
- 1 October 2000
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 20 (4) , 336-341
Assessment of Generic Health-related Quality of Life in Patients with Intermittent Claudication
- Open Access
- 1 April 1993
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 17 (4) , 777-779
Nonanastomotic pseudoaneurysm of expanded polytetrafluoroethylene axillofemoral bypass graft
- 1 April 1993
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 17 (4) , 777-779
Open AccessNonanastomotic pseudoaneurysm of expanded polytetrafluoroethylene axillofemoral bypass graft